NCT04310631View on ClinicalTrials.gov

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Coats Disease
Interventions
DRUG

Ranibizumab Injection

Ranibizumab Injection (0.5 mg/0.05 ml): Three monthly intravitreal injections

Trial Locations (1)

80100

"University of Naples Federico II", Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT04310631 - Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab | Biotech Hunter | Biotech Hunter